Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.
Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.
The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.
They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.
"Fantastic service, Really helpful & always able to source products that we need at very competitive prices. Would thoroughly recommend to any Veterinary Practice"
"Raman Pharma have been invaluable in sourcing drugs that are out of stock elsewhere. Delivery is rapid, costs are good and the customer service provided by Dhruv is excellent. I would definitely recommend this company and its services to others."
Public Health England (PHE) invites community pharmacy teams from across England to join a webinar about antimicrobial resistance (AMR) next week. This online event, being held on Thursday 29th August at 7.30pm, will help your pharmacy to make the most of the upcoming AMR campaign (which runs from 1st-30th September 2019). Participation in September’s campaign...
Department of Health and Social Care (DHSC) has today granted the following list of price concessions: Drug Pack size Price Concession Alverine 60mg capsules 100 £9.38 Betahistine 8mg tablets 84 £1.60 Celecoxib 200mg capsules 30 £8.00 Desmopressin 200microgram tablets 30 £14.58 Escitalopram 10mg tablets 28 £3.19 Hydroxychloroquine 200mg tablets 60 £5.74 Ibandronic acid 150mg tablets...
Two new ‘LPC Focus’ case studies have been published on the PSNC website. As part of PSNC’s work to identify and share best practice across the LPC network, Head of LPC Engagement and Collaboration Luvjit Kandula is developing a series of articles which provide an opportunity for LPCs to share their success, tips and good...
NHS Digital is seeking community pharmacy contractors to take part in a cyber and data security pilot. The NHS Digital data security centre will be working with cyber company, Templars, to contact and visit a selection of different types of pharmacy (e.g. independents, small chains and multiples). Collated findings from the visits will help to...
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 1 August 2019) has been published and includes articles on: Daratumumab (Darzalex▼): risk of reactivation of hepatitis B virus Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive Carfilzomib (Kyprolis▼): reminder of risk of potentially fatal cardiac...
The Community Pharmacy Competence Group (CPCG) has published an updated version (Version 3, August 2019) of the Vaccination Services Declaration of Competence (DoC). Pharmacists are required to complete the Vaccination services DoC every two years as part of the requirements to be able to offer the NHS Flu Vaccination Service. Following a review of the...
Following the announcement of a five-year deal on the Community Pharmacy Contractual Framework (CPCF), PSNC is holding a series of Sunday roadshow events for community pharmacists across England. The Roadshow begins in just under a week’s time, with events being held in Darlington and Doncaster on Sunday 25th August, so there is not long left...
NHS Digital has confirmed that a new Patient Medication Record (PMR) system called Titan has been granted Electronic Prescription Service (EPS) accreditation. The system supplier, Invatechhealth, has set out details about the system on their website. Their contact details and a link to their website is listed alongside other supplier details here. PSNC recommends that...
Community pharmacies will be required to have a shared NHSmail account to deliver the Community Pharmacist Consultation Service (CPCS), but only accounts listed accurately in the NHSmail pharmacy directory will be recognised as meeting this requirement. Whilst most pharmacies will have their NHSmail set up correctly, contractors are advised to make sure that their pharmacy’s...
This year’s Pharmacy Show will be taking place on Sunday 6th and Monday 7th October 2019 at the NEC in Birmingham. Registration for the two-day event is free, and community pharmacy contractors and their teams, as well as other healthcare and allied healthcare industry professionals, are now able to register for the event on the...
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
Dr June Raine will become interim Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) from 20 September 2019.
Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor the Commission on Human Medicines.
Establish hepatitis B virus status before initiating daratumumab and in patients with unknown hepatitis B virus serology who are already being treated with daratumumab.
Advise patients that naltrexone/bupropion has been associated with adverse reactions such as dizziness or somnolence, which can affect ability to drive, operate machinery, or perform dangerous tasks. Advise patients not to drive if they suspect their ability may be impaired.
Anti-cancer therapy with carfilzomib has been associated with cases of cardiac arrest, cardiac failure, and myocardial infarction, including in patients without pre-existing cardiac disorders. Monitor patients for signs and symptoms of cardiac disorders before and during exposure to carfilzomib.
Letters were sent about Oncaspar▼ (pegaspargase), Ketalar (ketamine) injection, and Elmiron (pentosan polysulfate sodium). A recall was issued for several medicines taken out of the regulated medicines supply chain, including a patient-level recall for Neupro 4mg/24hr patches and Vimpat 100mg tablets.
Alerts were issued about Telefunken automated external defibrillators and BD Microtainer capillary blood specimen collection tubes.
List of field safety notices (FSNs) from medical device manufacturers from 12 to 16 August 2019.
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
How to license a medicine for sale in the UK and Europe, including applications through national, centralised and decentralised procedures.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Medicines that were granted a positive opinion under the early access to medicines scheme (EAMS) which has now expired.
Helps manufacturers and healthcare professionals understand the definition of assistive technology and the difference between medical devices and aids to daily living.
Data on the time taken by MHRA to assess clinical trial applications and substantial amendments.
How to apply for, update and cancel licences for the manufacture, import and wholesale of human and veterinary medicines.
List of field safety notices (FSNs) from medical device manufacturers from 5 to 9 August 2019
You must get permission to export certain drugs and medicines.
Marketing authorisations granted in July 2019
Parallel import licenses granted in July 2019
How to legally run a business that deals with the wholesale of animal medicines (veterinary medicinal products) and the WDA Register.
Information for the pharmaceutical industry on new timetables and process improvements for national applications for MAs, ATCs and VHRs.
Web services, such as the Special Imports System and Adverse Event Reporting will be unavailable due to essential electrical maintenance.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
You must get permission to export certain drugs and medicines.
Reporting against VMD published standards up to 31 July 2019.
As of 9 August 2019 the VMD email addresses will be @vmd.gov.uk.
Details of seizure notice issued to Tudor House Animal Care Ltd, Wolverhampton, West Midlands. Published in August 2019.
Details of the improvement notice issued to Castlehill Veterinary Clinic, Dungannon, County Tyrone. Published in August 2019.
Availability of flunixin solutions for injection.
Report of the ten products for which most Special Import and Special Treatment Certificates (SIC and STC) have been issued by VMD in the UK.
Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 111.
The Veterinary Products Committee (VPC) is looking to appoint four new members.
This document contains the following information: Veterinary Medicines Directorate annual report and accounts 2018 to 2019.
How to comply with the exemption from the Veterinary Medicines Regulations that allow certain animal medicines to be sold without an authorisation.
Events VMD will be attending, hosting or participating in to support and advise industry and stakeholders.
The VMD wishes to make companies aware that fenbendazole is no longer permitted for use in pigeons under Schedule 6 (Exemptions for small pet animals) of the Veterinary Medicines Regulations (VMR) 2013.
Invitation to attend the joint VMD, VPC and Industry Information event for the pharmaceutical industry on Wednesday 25 September 2019
Residues of veterinary medicines in food 2019 surveillance results.
Residues of veterinary medicines in food 2018 surveillance results.
Back in February, the companies revealed results from the Phase III ARCHES trial in men with mHSPC.
Novo Nordisk submitted label updates in March this year.
Sir Andrew Dillon has led the organisation for 20 years.
Eligible patients in England and Wales will have access to the drug almost two months earlier.
The drug could now be administered every eight weeks compared to every four.
The letter urges for regulation to restrict price promotions on food and drink products high in fat, sugar and salt.
Both products are approved in adults for osteoporosis in various indications.
The injection was made as the last two decades have witnessed dramatic, unpredicted changes in fertility levels.
The 'life-changing' drug will be reimbursed for certain people with severe congenital haemophilia A.
The drug giant reported that in the primary analysis population the combination did not meet the primary endpoint.
IQVIA have been confirmed to host the head-to-head finals day at their offices based in Reading on the 13th of September.
The report also revealed that 2% of pupils had recently smoked, drunk alcohol and taken drugs and 11% had done only one of these recent behaviours.
The company say they are “surprised” to have received the letter.
The funding comes as part of the government’s commitment to transforming mental health care.
Forxiga has had a string of successes recently, as it was recommended by NICE and had its EU marketing authorisation updated earlier this month.
Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF
Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.
- +44 (0)1252 260 460.
- +44 (0)1276 469 290
Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available
